title: Anti-tuberculosis drug-induced hepatitis in renal transplant patient with pulmonary and extra pulmonary tuberculosis.
abstract: Hepatotoxicity is a major side-effect of the medicines used in tuberculosis therapy. Although the guidelines for the management of antituberculosis drug induced hepatitis have been published from varieties of health institutes and organizations, they are to a great extent highly similar, there are nevertheless some important differences. We report a case of hepatitis in a renal transplant recipient admitted with pulmonary and extra pulmonary (abdominal) tuberculosis and review the literature on this topic. The introduction of antimicrobial teams, including specialist pharmacists, microbiologists and infectious disease physicians, is a major factor to improve the quality of care and faces the overcoming of antimicrobial resistance. Reintroducing one antituberculosis drug at a time with close monitoring of liver enzymes seems to be the optimal approach in the management of antituberculosis drug induced hepatitis. With multi-disciplinary clinical approach the patient has been successfully cured and has returned to normal active life.
authors: Ministry of Health, Royal Hospital, Pharmacy Department, P.O. Box 1331, CPO, Postal Code 111, Muscat, Sultanate of Oman, Oman.
authors: Zaher
authors: Z
authors: Al-Salmi
keywords: Anti-tuberculosis; Hepatitis; Hepatotoxicity; Infectious disease; Pharmacist; Renal transplantation
references: Ann Intern Med. 2002 Oct 15;137(8):640-7
references: 12379063
references: Kekkaku. 2005 Sep;80(9):607-11
references: 16245792
references: J Antimicrob Chemother. 2004 Aug;54(2):295-8
references: 15201228
references: Antimicrob Agents Chemother. 2003 Feb;47(2):653-7
references: 12543673
references: MMWR Morb Mortal Wkly Rep. 2001 Aug 31;50(34):733-5
references: 11787580
references: J Infect. 2009 Sep;59(3):167-87
references: 19643501
references: Ann Intern Med. 2008 Nov 18;149(10):689-97
references: 19017587
references: J Gastroenterol Hepatol. 2008 Feb;23(2):192-202
references: 17995946
references: Eur Respir J. 1999 Oct;14(4):978-92
references: 10573254
references: Eur Respir J. 2007 Feb;29(2):347-51
references: 17005575
references: J Infect Dis. 1988 May;157(5):869-76
references: 3361154
references: Ann Pharmacother. 2006 Feb;40(2):304-6
references: 16391006
references: Am J Respir Crit Care Med. 2003 Feb 15;167(4):603-62
references: 12588714
references: N Engl J Med. 2006 Feb 16;354(7):731-9
references: 16481640
references: Pharmacotherapy. 2003 Jan;23(1):113-32
references: 12523470
references: Thorax. 1998 Jul;53(7):536-48
references: 9797751
references: Am J Respir Crit Care Med. 2006 Oct 15;174(8):935-52
references: 17021358
references: Int J Tuberc Lung Dis. 2001 Jan;5(1):65-9
references: 11263519
references: Transpl Infect Dis. 2010 Apr;12(2):106-12
references: 20002613
references: Int J Tuberc Lung Dis. 2005 May;9(5):534-40
references: 15875925
references: Thorax. 2010 Jun;65(6):557-70
references: 20522863